These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2831364)

  • 1. Synthesis and biological activity of ketomethylene-containing nonapeptide analogues of snake venom angiotensin converting enzyme inhibitors.
    Almquist RG; Chao WR; Judd AK; Mitoma C; Rossi DJ; Panasevich RE; Matthews RJ
    J Med Chem; 1988 Mar; 31(3):561-7. PubMed ID: 2831364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of [3H]captopril binding by peptide analog angiotensin converting enzyme inhibitors.
    Toll L; Almquist RG
    Biochem Biophys Res Commun; 1986 Mar; 135(3):770-7. PubMed ID: 3008745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors: synthesis and biological activity of N-substituted tripeptide inhibitors.
    Sawayama T; Tsukamoto M; Sasagawa T; Nishimura K; Deguchi T; Takeyama K; Hosoki K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):110-5. PubMed ID: 2159850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
    Cushman DW; Cheung HS; Sabo EF; Rubin B; Ondetti MA
    Fed Proc; 1979 Dec; 38(13):2778-82. PubMed ID: 228989
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and antienzymic activity of two new angiotensin converting enzyme inhibitors.
    Dudkiewicz J; Suska T; Tautt J; Paruszewski R
    Pol J Pharmacol Pharm; 1991; 43(1):33-8. PubMed ID: 1663247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally administered angiotensin-converting enzyme-inhibitors captopril and isoleucine-proline-proline have distinct effects on local renin-angiotensin system and corticosterone synthesis in dextran sulfate sodium-induced colitis in mice.
    Salmenkari H; Holappa M; Forsgard RA; Korpela R; Vapaatalo H
    J Physiol Pharmacol; 2017 Jun; 68(3):355-362. PubMed ID: 28820392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary angiotensin-converting enzyme and its inhibition: a historical survey.
    Bakhle YS
    Ciba Found Symp; 1980; 78():275-92. PubMed ID: 6258881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitors.
    Soudijn W
    Pharm Weekbl Sci; 1982 Oct; 4(5):154-8. PubMed ID: 6292819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
    Michaud A; Williams TA; Chauvet MT; Corvol P
    Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of pentapeptide analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline.
    Almquist RG; Jennings-White C; Chao WR; Steeger T; Wheeler K; Rogers J; Mitoma C
    J Med Chem; 1985 Aug; 28(8):1062-6. PubMed ID: 2991517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.
    Jullien N; Makritis A; Georgiadis D; Beau F; Yiotakis A; Dive V
    J Med Chem; 2010 Jan; 53(1):208-20. PubMed ID: 19899765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
    Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T
    Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LmrBPP9: A synthetic bradykinin-potentiating peptide from Lachesis muta rhombeata venom that inhibits the angiotensin-converting enzyme activity in vitro and reduces the blood pressure of hypertensive rats.
    Pinheiro-Júnior EL; Boldrini-França J; de Campos Araújo LMP; Santos-Filho NA; Bendhack LM; Cilli EM; Arantes EC
    Peptides; 2018 Apr; 102():1-7. PubMed ID: 29410030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of angiotensin-converting enzyme.
    Cushman DW; Ondetti MA
    Prog Med Chem; 1980; 17():41-104. PubMed ID: 6273970
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulation.
    Snyder RA; Wintroub BU
    Biochim Biophys Acta; 1986 May; 871(1):1-5. PubMed ID: 3008847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
    Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function studies of BPP-BrachyNH
    Arcanjo DDR; Vasconcelos AG; Nascimento LA; Mafud AC; Plácido A; Alves MMM; Delerue-Matos C; Bemquerer MP; Vale N; Gomes P; Oliveira EB; Lima FCA; Mascarenhas YP; Carvalho FAA; Simonsen U; Ramos RM; Leite JRSA
    Eur J Med Chem; 2017 Oct; 139():401-411. PubMed ID: 28810191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.